13F Data
13F filer · CIK 1503556

MV Management XI, L.L.C.

Menlo Park, CA · filing since Q4 2021 · last filing Nov 14, 2023
Reported value
$60.1M
+$3.0M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $9.1M
Top-10 weight
100.0%

Biggest buys vs Q2 2023

No new or increased positions this quarter.

Biggest sells vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
ReducedRECURSION PHARMACEUTICALS IN-1,183,146-60.0%$-9.1M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $231.5MQ1 2022: $144.0MQ2 2022: $110.0MQ3 2022: $138.0MQ4 2022: $57.5MQ1 2023: $65.3MQ2 2023: $57.2MQ3 2023: $60.1M
Q4 2021Q3 2023

Holdings · Q3 2023

#SecuritySharesValueWeight
1ROVER GROUP INCCOM CL A8,638,513$54.1M89.96%
2RECURSION PHARMACEUTICALS INCL A788,762$6.0M10.04%
3ANGI INCCOM CL A NEW1,898$3.8K0.01%